The Pre-Stem Cell Therapy Panel (PreSCT) is a multi-marker panel for the detection of occult cancerous process prior to the administration of stem cell therapy. Also included are Vitamin D and Hyaluronic Acid for supporting and monitoring outcomes of therapy.


Don’t Throw Fuel On A Fire

Stem cells should not be given to dogs with active tumors.  The introduction of additional, undifferentiated cells, may cause tumor growth – essentially adding fuel to the fire. Using a DNA proliferation marker TK1, and inflammatory marker CRP, the Pre-SCT Panel is sensitive to hidden tumor activity.  When everything is normal, your patient will have the green-light to receive therapy.

Candidates

Dogs intending to undergo Stem Cell Therapy should be evaluated using the Pre-SCT Panel to ensure there is no hidden cancer prior to therapy.  Post-therapy, reflex to the Osteoarthritis Panel (OA Panel) for monitoring. 

Exclusions

Dogs with known cancer, active VBD, liver disease, or recent physical trauma should not be evaluated.  Additionally, patients on corticosteroids and NSAIDs should contact VDI prior to testing.


Evaluate Outcome Success & Monitor SCT Patients

Hyaluronic Acid (HA) is a marker of joint degeneration. Setting a baseline level allows for a quantitative evaluation of outcomes as well as for monitoring long term disease progression. Learn more about hyaluronic acid and monitoring on the Osteoarthritis Panel.

Pre-SCT Panel includes Vitamin D

Vitamin D has multiple roles in the body, but two critical to stem cell therapy: immune-modulation and cell differentiation/activation, both of which may have an impact on the success of therapy. It’s well documented that most unsupplemented dogs are VitD insufficient. The associated Vitamin D report that comes with this panel has patient specific dosing guidelines to correct any insufficiencies.